Roche announced additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant

On Dec. 3, 2021, Roche and TIB Molbiol announced they had added three additional Research Use Only test kits for the detection of mutations present in the novel B.1.1.529 Omicron SARS-CoV-2 variant: VirSNip SARS Spike ins214EPE (RUO), VirSNiP SARS-CoV-2 Spike S371L S373P (RUO), VirSNip SARS Spike E484A (RUO).

The VirSNiP variant kits allow differentiation between unique mutations present within the Omicron variant compared to other SARS-CoV-2 variants and are for use on LightCyclerﾮ and cobasﾮ z 480 analysers.

Tags:

Source: Roche
Credit:

Visit News/History Source
LifeScienceHistory.com offers three advertising package options. Each package lnclude at least two digital images for multiple page placements and maximum exposure! Rates range from just $300 to $500 per month.